You are here: Home » Opinion » Columns
Business Standard

Medicinal plants await good marketing

Fortunately, India is endowed with a huge and diversified wealth of plant species having curative traits

Topics
BS Opinion | Treatment plants | Medicines

Surinder Sud 

Surinder Sud

The cultivation of medicinal plants has become a lucrative agribusiness, thanks to the increasing use of relatively safe and affordable plant-based remedies for common ailments. With the depletion of the herbal resources of forests, which have typically been the main source of procuring therapeutically important vegetation, these plants now need to be grown on agricultural fields to meet their burgeoning demand from the pharmaceutical, cosmetics, and other industries. These plants generally do not require much investment, or large landholdings, to grow but give high returns. Some knowledge of the plant-specific agronomic practices is, no doubt, helpful to get good yields but this information is now readily available from various sources. Many public- and private-sector institutions provide training in growing medicinal plants. Most of the large manufacturers of herbal drugs and other value-added products prefer to go in for contract farming of these plants, guaranteeing the growers to buy their entire produce at mutually agreed prices. Several farmers’ producer organisations and start-ups have also entered this field. Many of them have developed their own brands as well. Most importantly, exports of curative herbs, their extracts, and other products are also going up. India shipped Ayurvedic drugs, skincare products, and other herbal items worth around $539 million in 2019-20, mostly to Europe and other developed countries.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sun, April 17 2022. 22:35 IST
RECOMMENDED FOR YOU